The Ozurdex trial compared a single dexamethasone implant, at a dose of 0.7 or 0.35 mg, with a sham implant, in adults with branch RVO (BRVO)-ME and CRVO-ME of 6 weeks to 9 months' duration ...
We recently published a list of These 10 Stocks Posted Double-, Triple-Digit Gains Last Week. In this article, we are going to take a look at where CervoMed Inc. (NASDAQ:CRVO) stands against other ...
Fintel reports that on March 13, 2025, Jones Trading upgraded their outlook for CervoMed (NasdaqCM:CRVO) from Hold to Buy. As of March 4, 2025, the average one-year price target for CervoMed is $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback